FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385548008: Ibritumomab tiuxetan (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1459727019 Ibritumomab tiuxetan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1479753011 Ibritumomab tiuxetan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
931821000195111 ibritumomab tiuxetan it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191661000077112 ibritumomab tiuxetan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
817061000172113 ibritumomab tiuxétan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
672341000274119 Ibritumomab-Tiuxetan de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibritumomab tiuxetan (substance) Is a agent d'anticorps monoclonal false Inferred relationship Some
Ibritumomab tiuxetan (substance) Is a Immunosuppressant (substance) false Inferred relationship Some
Ibritumomab tiuxetan (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Ibritumomab tiuxetan (substance) Is a Monoclonal antibody true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ibritumomab tiuxetan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibritumomab tiuxetan (substance) Inferred relationship Some 1
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Some
Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Some
Ibritumomab tiuxetan 1.6mg/mL radiopharmaceutical infusion kit The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Ibritumomab tiuxetan (substance) Inferred relationship Some
Injection of indium 111 and ibritumomab tiuxetan Direct substance True Ibritumomab tiuxetan (substance) Inferred relationship Some 3
Product containing only ibritumomab tiuxetan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ibritumomab tiuxetan (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start